These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18267243)

  • 21. Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems.
    Miller RM; Federoff HJ
    Neuroscientist; 2005 Dec; 11(6):539-49. PubMed ID: 16282595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila.
    Park J; Kim Y; Chung J
    Dis Model Mech; 2009; 2(7-8):336-40. PubMed ID: 19553694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R; Merchant KM; Ryan T
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
    Harrington AJ; Hamamichi S; Caldwell GA; Caldwell KA
    Dev Dyn; 2010 May; 239(5):1282-95. PubMed ID: 20108318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the genetics of Parkinson's disease.
    Rosner S; Giladi N; Orr-Urtreger A
    Acta Pharmacol Sin; 2008 Jan; 29(1):21-34. PubMed ID: 18158863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ; Fox SA; Caldwell GA; Caldwell KA
    Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.
    Grünblatt E
    Expert Rev Neurother; 2008 Dec; 8(12):1865-77. PubMed ID: 19086884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The experimental models of Parkinson's disease in animals].
    Grigor'ian GA; Bazian AS
    Usp Fiziol Nauk; 2007; 38(4):80-8. PubMed ID: 18064910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage.
    Hauser MA; Li YJ; Takeuchi S; Walters R; Noureddine M; Maready M; Darden T; Hulette C; Martin E; Hauser E; Xu H; Schmechel D; Stenger JE; Dietrich F; Vance J
    Hum Mol Genet; 2003 Mar; 12(6):671-7. PubMed ID: 12620972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR: a therapeutic target in Parkinson's disease.
    Chaturvedi RK; Beal MF
    J Neurochem; 2008 Jul; 106(2):506-18. PubMed ID: 18384649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
    Singh MP; Patel S; Dikshit M; Gupta YK
    Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
    Fu Y; Ito M; Fujita Y; Ito M; Ichihara M; Masuda A; Suzuki Y; Maesawa S; Kajita Y; Hirayama M; Ohsawa I; Ohta S; Ohno K
    Neurosci Lett; 2009 Apr; 453(2):81-5. PubMed ID: 19356598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.
    Wu G; Yan B; Wang X; Feng X; Zhang A; Xu X; Dong H
    J Neurol Sci; 2008 Aug; 271(1-2):168-73. PubMed ID: 18495164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of JNK pathway in familial Parkinson's disease].
    Jankowski M
    Postepy Biochem; 2007; 53(3):297-303. PubMed ID: 18399358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease.
    Arai T; Fukae J; Hatano T; Kubo S; Ohtsubo T; Nakabeppu Y; Mori H; Mizuno Y; Hattori N
    Acta Neuropathol; 2006 Aug; 112(2):139-45. PubMed ID: 16773329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
    Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.